Key facts
- Ainst’s last known valuation is $8.0M (Mar 2017).
- It has raised $1.4M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Marathon Venture Partners, Haiyin Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Ainst
- ·The full record, as it builds
Funding rounds
No funding rounds for Ainst are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ainst
Provider of overall clinical nutrition solutions designed for medical institutions. The company's clinical nutrition service platform integrates nutrition diagnosis and treatment equipment, clinical nutrition software, and intelligent nutrition medical cabinet, enabling tumor patients to monitor their nutritional status and recover as soon as possible.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2011
- Website
- ainst.com/
- Ownership
- Privately Held (backing)
Ainst doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ainst shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ainst in its N-PORT filings yet. We sweep new filings monthly.